Pharmacological actions and potential uses of Momordica charantia: a review

This publication has 102 references indexed in Scilit:

• Anti-HIV Agent MAP30 Modulates the Expression Profile of Viral and Cellular Genes for Proliferation and Apoptosis in AIDS-Related Lymphoma Cells Infected with Kaposi's Sarcoma-Associated Virus
  Biochemical and Biophysical Research Communications, 2001
• Proteolytic Fragments of Anti-HIV and Anti-tumor Proteins MAP30 and GAP31 Are Biologically Active
  Biochemical and Biophysical Research Communications, 1999
• Antidiabetic Principles of Natural Medicines. III. Structure-Related Inhibitory Activity and Action Mode of Oleanolic Acid Glycosides on Hypoglycemic Activity.
  CHEMICAL & PHARMACEUTICAL BULLETIN, 1998
• Anti-diabetic properties and phytochemistry of Momordica charantia L. (Cucurbitaceae)
  Phytomedicine, 1996
• In vitro and in vivo properties of an anti-CD5—momordin immunotoxin on normal and neoplastic T lymphocytes
  Cancer Immunology, Immunotherapy, 1993
• Effects of -trichosanthin and -momorcharin on the development of peri-implantation mouse embryos
  Reproduction, 1983
• The immunomodulatory activity of the plant proteins Momordica Charantia inhibitor and Pokeweed antiviral protein
  International Journal of Immunopharmacology, 1983
• Effect of ribosome-inactivating proteins on virus-infected cells. Inhibition of virus multiplication and of protein synthesis
  Archiv für die gesamte Virusforschung, 1982
• Partial purification and characterization of a guanylate cyclase inhibitor with cytotoxic properties from the bitter melon (Momordica charantia)
  Biochemical and Biophysical Research Communications, 1980
• Isolation of a guanylate cyclase inhibitor from the balsam pear (Momordica charantia abreviata)
  Biochemical and Biophysical Research Communications, 1977